Home > Research > Publications & Outputs > Autism Spectrum Social Stories In Schools Trial...

Electronic data

  • e005952.full

    Rights statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work noncommercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/

    Final published version, 603 KB, PDF document

    Available under license: CC BY-NC: Creative Commons Attribution-NonCommercial 4.0 International License

Links

Text available via DOI:

View graph of relations

Autism Spectrum Social Stories In Schools Trial (ASSSIST): study protocol for a feasibility randomised controlled trial analysing clinical and cost-effectiveness of Social Stories in mainstream schools

Research output: Contribution to journalJournal articlepeer-review

Published

Standard

Autism Spectrum Social Stories In Schools Trial (ASSSIST) : study protocol for a feasibility randomised controlled trial analysing clinical and cost-effectiveness of Social Stories in mainstream schools. / Wright, Barry; Marshall, David; Collingridge Moore, Danielle; Ainsworth, Hannah; Hackney, Lisa; Adamson, Joy; Ali, Shehzad; Allgar, Victoria; Cook, Liz; Dyson, Lisa; Littlewood, Elizabeth; Hargate, Rebecca; McLaren, Anne; McMillan, Dean; Trépel, Dominic; Whitehead, Jo; Williams, Chris.

In: BMJ Open, Vol. 4, No. 7, e005952, 09.07.2014.

Research output: Contribution to journalJournal articlepeer-review

Harvard

Wright, B, Marshall, D, Collingridge Moore, D, Ainsworth, H, Hackney, L, Adamson, J, Ali, S, Allgar, V, Cook, L, Dyson, L, Littlewood, E, Hargate, R, McLaren, A, McMillan, D, Trépel, D, Whitehead, J & Williams, C 2014, 'Autism Spectrum Social Stories In Schools Trial (ASSSIST): study protocol for a feasibility randomised controlled trial analysing clinical and cost-effectiveness of Social Stories in mainstream schools', BMJ Open, vol. 4, no. 7, e005952. https://doi.org/10.1136/bmjopen-2014-005952

APA

Wright, B., Marshall, D., Collingridge Moore, D., Ainsworth, H., Hackney, L., Adamson, J., Ali, S., Allgar, V., Cook, L., Dyson, L., Littlewood, E., Hargate, R., McLaren, A., McMillan, D., Trépel, D., Whitehead, J., & Williams, C. (2014). Autism Spectrum Social Stories In Schools Trial (ASSSIST): study protocol for a feasibility randomised controlled trial analysing clinical and cost-effectiveness of Social Stories in mainstream schools. BMJ Open, 4(7), [e005952]. https://doi.org/10.1136/bmjopen-2014-005952

Vancouver

Author

Wright, Barry ; Marshall, David ; Collingridge Moore, Danielle ; Ainsworth, Hannah ; Hackney, Lisa ; Adamson, Joy ; Ali, Shehzad ; Allgar, Victoria ; Cook, Liz ; Dyson, Lisa ; Littlewood, Elizabeth ; Hargate, Rebecca ; McLaren, Anne ; McMillan, Dean ; Trépel, Dominic ; Whitehead, Jo ; Williams, Chris. / Autism Spectrum Social Stories In Schools Trial (ASSSIST) : study protocol for a feasibility randomised controlled trial analysing clinical and cost-effectiveness of Social Stories in mainstream schools. In: BMJ Open. 2014 ; Vol. 4, No. 7.

Bibtex

@article{49d1a3f77d6f4c71a150dcfaaa8674e7,
title = "Autism Spectrum Social Stories In Schools Trial (ASSSIST): study protocol for a feasibility randomised controlled trial analysing clinical and cost-effectiveness of Social Stories in mainstream schools",
abstract = "INTRODUCTION: Current evidence suggests that Social Stories can be effective in tackling problem behaviours exhibited by children with autism spectrum disorder. Exploring the meaning of behaviour from a child's perspective allows stories to provide social information that is tailored to their needs. Case reports in children with autism have suggested that these stories can lead to a number of benefits including improvements in social interactions and choice making in educational settings.METHODS AND ANALYSIS: The feasibility of clinical and cost-effectiveness of a Social Stories toolkit will be assessed using a randomised control framework. Participants (n=50) will be randomised to either the Social Stories intervention or a comparator group where they will be read standard stories for an equivalent amount of time. Statistics will be calculated for recruitment rates, follow-up rates and attrition. Economic analysis will determine appropriate measures of generic health and resource use categories for cost-effectiveness analysis. Qualitative analysis will ascertain information on perceptions about the feasibility and acceptability of the intervention.ETHICS AND DISSEMINATION: National Health Service Ethics Approval (NHS; ref 11/YH/0340) for the trial protocol has been obtained along with NHS Research and Development permission from Leeds and York Partnership NHS Foundation Trust. All adverse events will be closely monitored, documented and reported to the study Data Monitoring Ethics Committee. At least one article in a peer reviewed journal will be published and research findings presented at relevant conferences.TRIAL REGISTRATION NUMBER: ISRCTN96286707.",
author = "Barry Wright and David Marshall and {Collingridge Moore}, Danielle and Hannah Ainsworth and Lisa Hackney and Joy Adamson and Shehzad Ali and Victoria Allgar and Liz Cook and Lisa Dyson and Elizabeth Littlewood and Rebecca Hargate and Anne McLaren and Dean McMillan and Dominic Tr{\'e}pel and Jo Whitehead and Chris Williams",
note = "This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work noncommercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/",
year = "2014",
month = jul,
day = "9",
doi = "10.1136/bmjopen-2014-005952",
language = "English",
volume = "4",
journal = "BMJ Open",
issn = "2044-6055",
publisher = "BMJ Publishing Group Ltd",
number = "7",

}

RIS

TY - JOUR

T1 - Autism Spectrum Social Stories In Schools Trial (ASSSIST)

T2 - study protocol for a feasibility randomised controlled trial analysing clinical and cost-effectiveness of Social Stories in mainstream schools

AU - Wright, Barry

AU - Marshall, David

AU - Collingridge Moore, Danielle

AU - Ainsworth, Hannah

AU - Hackney, Lisa

AU - Adamson, Joy

AU - Ali, Shehzad

AU - Allgar, Victoria

AU - Cook, Liz

AU - Dyson, Lisa

AU - Littlewood, Elizabeth

AU - Hargate, Rebecca

AU - McLaren, Anne

AU - McMillan, Dean

AU - Trépel, Dominic

AU - Whitehead, Jo

AU - Williams, Chris

N1 - This is an Open Access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work noncommercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/

PY - 2014/7/9

Y1 - 2014/7/9

N2 - INTRODUCTION: Current evidence suggests that Social Stories can be effective in tackling problem behaviours exhibited by children with autism spectrum disorder. Exploring the meaning of behaviour from a child's perspective allows stories to provide social information that is tailored to their needs. Case reports in children with autism have suggested that these stories can lead to a number of benefits including improvements in social interactions and choice making in educational settings.METHODS AND ANALYSIS: The feasibility of clinical and cost-effectiveness of a Social Stories toolkit will be assessed using a randomised control framework. Participants (n=50) will be randomised to either the Social Stories intervention or a comparator group where they will be read standard stories for an equivalent amount of time. Statistics will be calculated for recruitment rates, follow-up rates and attrition. Economic analysis will determine appropriate measures of generic health and resource use categories for cost-effectiveness analysis. Qualitative analysis will ascertain information on perceptions about the feasibility and acceptability of the intervention.ETHICS AND DISSEMINATION: National Health Service Ethics Approval (NHS; ref 11/YH/0340) for the trial protocol has been obtained along with NHS Research and Development permission from Leeds and York Partnership NHS Foundation Trust. All adverse events will be closely monitored, documented and reported to the study Data Monitoring Ethics Committee. At least one article in a peer reviewed journal will be published and research findings presented at relevant conferences.TRIAL REGISTRATION NUMBER: ISRCTN96286707.

AB - INTRODUCTION: Current evidence suggests that Social Stories can be effective in tackling problem behaviours exhibited by children with autism spectrum disorder. Exploring the meaning of behaviour from a child's perspective allows stories to provide social information that is tailored to their needs. Case reports in children with autism have suggested that these stories can lead to a number of benefits including improvements in social interactions and choice making in educational settings.METHODS AND ANALYSIS: The feasibility of clinical and cost-effectiveness of a Social Stories toolkit will be assessed using a randomised control framework. Participants (n=50) will be randomised to either the Social Stories intervention or a comparator group where they will be read standard stories for an equivalent amount of time. Statistics will be calculated for recruitment rates, follow-up rates and attrition. Economic analysis will determine appropriate measures of generic health and resource use categories for cost-effectiveness analysis. Qualitative analysis will ascertain information on perceptions about the feasibility and acceptability of the intervention.ETHICS AND DISSEMINATION: National Health Service Ethics Approval (NHS; ref 11/YH/0340) for the trial protocol has been obtained along with NHS Research and Development permission from Leeds and York Partnership NHS Foundation Trust. All adverse events will be closely monitored, documented and reported to the study Data Monitoring Ethics Committee. At least one article in a peer reviewed journal will be published and research findings presented at relevant conferences.TRIAL REGISTRATION NUMBER: ISRCTN96286707.

U2 - 10.1136/bmjopen-2014-005952

DO - 10.1136/bmjopen-2014-005952

M3 - Journal article

C2 - 25009139

VL - 4

JO - BMJ Open

JF - BMJ Open

SN - 2044-6055

IS - 7

M1 - e005952

ER -